{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:04:31Z","timestamp":1793941471527,"version":"4.8.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.exer.2021.108617","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T09:48:52Z","timestamp":1621158532000},"page":"108617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The role of peroxisome proliferator-activated receptors in healthy and diseased eyes"],"prefix":"10.1016","volume":"208","author":[{"given":"Paulina","family":"Escandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-3120","authenticated-orcid":false,"given":"Brenda","family":"Vasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8983-6012","authenticated-orcid":false,"given":"Amy E.","family":"Whelchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Greg","family":"Matlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8761-3824","authenticated-orcid":false,"given":"Dimitrios","family":"Karamichos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108617_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.reprotox.2008.10.001","article-title":"Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR\u03b3) in rodent and human development","volume":"27","author":"Abbott","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.exer.2021.108617_bib2","article-title":"The trabecular meshwork: a basic review of form and function","volume":"2","author":"Abu-Hassan","year":"2014","journal-title":"J. Ocul. Biol."},{"key":"10.1016\/j.exer.2021.108617_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2021.108617_bib5","first-page":"516","article-title":"Oxygen distribution in the macaque retina","volume":"34","author":"Ahmed","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-809324-5.01307-9","article-title":"Anti-angiogenic properties of vitreous","author":"Ahmed","year":"2017","journal-title":"Ref. Modul. Neurosci. Biobehav. Psychol."},{"key":"10.1016\/j.exer.2021.108617_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archophthalmol.2009.310","article-title":"Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy","volume":"128","author":"Ambrosius","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib8","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1167\/iovs.02-1060","article-title":"Role of PPAR-\u03b3 ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells","volume":"44","author":"Aoun","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2021.108617_bib9","first-page":"1","article-title":"Corneal blindness-- a review","volume":"27","author":"Aurora","year":"1979","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib10","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.exer.2021.108617_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.012610299","article-title":"Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer","volume":"99","author":"Barak","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108617_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol. Cell."},{"key":"10.1016\/j.exer.2021.108617_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbr.2014.08.014","article-title":"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine","volume":"274","author":"Barbiero","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.exer.2021.108617_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196943","article-title":"Probing the role of PPAR\u03b3 in the regulation of late-onset Alzheimer's disease-associated genes","author":"Barrera","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108617_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/108076803322660495","article-title":"Peroxisome proliferator-activated receptor agonists inhibit interleukin-1\u03b2-mediated nitric oxide production in cultured lacrimal gland acinar cells","volume":"19","author":"Beauregard","year":"2003","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.exer.2021.108617_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1364\/AO.10.000459","article-title":"Theory of transparency of the eye","volume":"10","author":"Benedek","year":"1971","journal-title":"Appl. Opt."},{"key":"10.1016\/j.exer.2021.108617_bib17","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI118687","article-title":"Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice","volume":"97","author":"Berthou","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2021.108617_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.visres.2017.06.016","article-title":"Hematopoietic stem\/progenitor involvement in retinal microvascular repair during diabetes: implications for bone marrow rejuvenation","volume":"139","author":"Bhatwadekar","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2021.108617_bib19","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2337\/db07-0765","article-title":"Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism","volume":"57","author":"Biscetti","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib20","doi-asserted-by":"crossref","first-page":"825970","DOI":"10.1155\/2008\/825970","article-title":"A role for PPARbeta\/delta in ocular angiogenesis","author":"Bishop-Bailey","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pbiomolbio.2003.11.012","article-title":"Ageing and vision: structure, stability and function of lens crystallins","volume":"86","author":"Bloemendal","year":"2004","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.exer.2021.108617_bib22","series-title":"Glaucoma - Basic and Clinical Aspects","first-page":"3","article-title":"Anatomy of ciliary body, ciliary processes, anterior chamber angle and collector vessels","author":"Borges-Giampani","year":"2013"},{"key":"10.1016\/j.exer.2021.108617_bib23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s11695-007-9172-5","article-title":"Adipose tissue distribution and quantification of PPAR\u03b2\/\u03b4 and PPAR\u03b31-3 mRNAs: discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients","volume":"17","author":"Bortolotto","year":"2007","journal-title":"Obes. Surg."},{"key":"10.1016\/j.exer.2021.108617_bib24","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1194\/jlr.M034132","article-title":"Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy","volume":"54","author":"Brautbar","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.exer.2021.108617_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-003-0018-6","article-title":"Polymorphism in the peroxisome proliferator-activated receptor\u00a0? gene influences the risk for Alzheimer's disease","volume":"110","author":"Brune","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.exer.2021.108617_bib26","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1167\/iovs.13-11608","article-title":"Peroxisome proliferator-activated receptor- \u03b2\/\u03b4 regulates angiogenic cell behaviors and oxygen-induced retinopathy","volume":"54","author":"Capozzi","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib27","doi-asserted-by":"crossref","DOI":"10.11131\/2018\/101370","article-title":"Physiology and pathophysiology of PPARs in the eye","volume":"5","author":"Castelli","year":"2018","journal-title":"Nucl. Recept. Res."},{"key":"10.1016\/j.exer.2021.108617_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1043-6618(92)90232-Z","article-title":"Mode of action of fibrates","volume":"26","author":"Catapano","year":"1992","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2021.108617_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2012.04.006","article-title":"Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension","volume":"658","author":"Cervantes-Perez","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2021.108617_bib30","first-page":"242643","article-title":"PPARs in rhythmic metabolic regulation and implications in health and disease","author":"Charoensuksai","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","article-title":"PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation","volume":"7","author":"Chawla","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2021.108617_bib32","article-title":"PPARs integrate the mammalian clock and energy metabolism","volume":"653017","author":"Chen","year":"2014","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib33","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2337\/db16-1246","article-title":"Pathogenic role of microRNA-21 in diabetic retinopathy through downregulation of PPAR\u03b1","volume":"66","author":"Chen","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPAR\u03b1 agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib35","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1167\/iovs.12-10916","article-title":"Studying the effect of Iris mechanics on the pupillary light reflex using brimonidine-induced anisocoria","volume":"54","author":"Chen","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPAR\u03b1 agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib37","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3892\/mmr.2014.2041","article-title":"Decreased PPAR-\u03b3 expression in the conjunctiva and increased expression of TNF-\u03b1 and IL-1\u03b2 in the conjunctiva and tear fluid of dry eye mice","volume":"9","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exer.2021.108617_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) and neurodegenerative disorders","volume":"46","author":"Chen","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.exer.2021.108617_bib39","first-page":"95","article-title":"Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells","volume":"14","author":"Cheng","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108617_bib40","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.2337\/db16-0426","article-title":"Interaction of PPAR\u03b1 with the canonic Wnt pathway in the regulation of renal fibrosis","volume":"65","author":"Cheng","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR\u03b3 by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exer.2021.108617_bib43","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.18632\/aging.101031","article-title":"Ppar\u03b2\/\u03b4 selectively regulates phenotypic features of age-related macular degeneration","volume":"8","author":"Choudhary","year":"2016","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.exer.2021.108617_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543784.2013.839659","article-title":"Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases","volume":"23","author":"Colca","year":"2014","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.exer.2021.108617_bib45","doi-asserted-by":"crossref","first-page":"549691","DOI":"10.1155\/2015\/549691","article-title":"PPAR\u03b3 and the innate immune system mediate the resolution of inflammation","volume":"2015","author":"Croasdell","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib46","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.4049\/jimmunol.168.6.2795","article-title":"Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors","volume":"168","author":"Cunard","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108617_bib47","first-page":"537818","article-title":"Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: a case report and literature review","author":"Danis","year":"2010","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.exer.2021.108617_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10408444.2017.1351420","article-title":"Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future","volume":"48","author":"Davidson","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.exer.2021.108617_bib49","doi-asserted-by":"crossref","first-page":"108090","DOI":"10.1016\/j.exer.2020.108090","article-title":"Descemet's membrane development, structure, function, and regeneration","volume":"197","author":"de Oliveira","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1569-2590(05)10005-6","article-title":"Ciliary body and ciliary epithelium","volume":"10","author":"Delamere","year":"2005","journal-title":"Adv. Organ Biol."},{"key":"10.1016\/j.exer.2021.108617_bib51","first-page":"1029","article-title":"DNA binding-independent induction of I\u03baB\u03b1 gene transcription by PPAR\u03b1","volume":"16","author":"Delerive","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.exer.2021.108617_bib52","doi-asserted-by":"crossref","first-page":"36703","DOI":"10.1074\/jbc.M004045200","article-title":"Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators","volume":"275","author":"Delerive","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib53","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2165\/00003495-200464190-00003","article-title":"Role of fibric acid derivatives in the management of risk factors for coronary heart disease","volume":"64","author":"Despres","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2021.108617_bib54","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.exer.2021.108617_bib55","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.ajpath.2014.06.021","article-title":"Peroxisome proliferator- activated receptor \u03b1 protects capillary pericytes in the retina","volume":"184","author":"Ding","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108617_bib56","article-title":"Intestinal PPAR\u03b4 protects against diet-induced obesity, insulin resistance and dyslipidemia","volume":"846","author":"Doktorova","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2021.108617_bib57","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exer.2021.108617_bib58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","article-title":"Peroxisome proliferator-activated receptor gamma-mediated effects in the vasculature","volume":"102","author":"Duan","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2021.108617_bib59","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1471-4159.2009.06286.x","article-title":"Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration","volume":"110","author":"Ebert","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2021.108617_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-4274(98)00042-3","article-title":"Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway","volume":"98","author":"Edgar","year":"1998","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.exer.2021.108617_bib61","series-title":"Reference Module in Neuroscience and Biobehavioral Psychology","article-title":"Anatomy and regulation of the optic nerve blood Flow'","author":"Ehrlich","year":"2017"},{"key":"10.1016\/j.exer.2021.108617_bib62","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2008.12.071","article-title":"Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model","volume":"379","author":"Escribano","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2021.108617_bib63","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/14728222.2011.581231","article-title":"Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury","volume":"15","author":"Esposito","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.exer.2021.108617_bib64","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1152\/jn.2000.83.4.1817","article-title":"Light-evoked responses of bipolar cells in a mammalian retina","volume":"83","author":"Euler","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.exer.2021.108617_bib66","series-title":"Quantitative Human Physiology","article-title":"Vision","author":"Feher","year":"2012"},{"key":"10.1016\/j.exer.2021.108617_bib67","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2174\/0929867321666140303143455","article-title":"Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPAR\u03b1) and its lipid ligands","volume":"21","author":"Fidaleo","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib68","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ajo.2008.10.016","article-title":"Glitazone use associated with diabetic macular edema","volume":"147","author":"Fong","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib69","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors \u03b1 and \u03b4","volume":"94","author":"Forman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108617_bib70","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.exer.2021.108617_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/srep10839","article-title":"Low-glucose enhances keratocyte-characteristic phenotype from corneal stromal cells in serum-free conditions","volume":"5","author":"Foster","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2021.108617_bib72","doi-asserted-by":"crossref","first-page":"45629","DOI":"10.1074\/jbc.M303292200","article-title":"Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis","volume":"278","author":"Funderburgh","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib73","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1101\/gad.178434.111","article-title":"The nuclear receptor PPAR\u03b2\/\u03b4 programs muscle glucose metabolism in cooperation with AMPK and MEF2","volume":"25","author":"Gan","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.exer.2021.108617_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-38","article-title":"Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease","author":"Garrido-Gil","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108617_bib75","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/13543784.16.10.1561","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands as investigational modulators of angiogenesis","volume":"16","author":"Giaginis","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.exer.2021.108617_bib76","article-title":"Integrative and systemic approaches for evaluating PPAR\u03b2\/\u03b4 (PPARD) function","volume":"13","author":"Giordano Attianese","year":"2015","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.exer.2021.108617_bib77","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbrc.2008.04.086","article-title":"Quantitative expression patterns of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) protein in mice","volume":"371","author":"Girroir","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2021.108617_bib78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajo.2017.12.007","article-title":"Lack of longitudinal association between thiazolidinediones and incidence and progression of diabetic eye disease: the ACCORD eye study","volume":"187","author":"Gower","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib79","first-page":"67","article-title":"Thiazolidinediones-mechanisms of action","volume":"27","author":"Greenfield","year":"2004","journal-title":"Exp. Clin. Pharmacol."},{"key":"10.1016\/j.exer.2021.108617_bib239","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1167\/iovs.18-24239","article-title":"Inhibition of human corneal myofibroblast formation","volume":"59","author":"Guo","year":"2018","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib80","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.05-1480","article-title":"Regulation of eye size by the retinal basement membrane and vitreous body","volume":"47","author":"Halfter","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.exer.2021.108617_bib81","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.exer.2010.06.021","article-title":"The molecular basis of corneal transparency","volume":"91","author":"Hassell","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib82","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1167\/iovs.12-10488","article-title":"Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-\u03b2 are prevented by PPAR-\u03b3 agonists","volume":"53","author":"Hatanaka","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib83","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1002\/dmrr.249","article-title":"The mode of action of thiazolidinediones","volume":"18","author":"Hauner","year":"2002","journal-title":"Diabetes Metabol. Res. Rev."},{"key":"10.1016\/j.exer.2021.108617_bib84","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1167\/iovs.61.3.54","article-title":"PPAR\u03b1 agonist Fenofibrate suppressed the formation of ocular surface squamous metaplasia induced by topical benzalkonium chloride","volume":"61","author":"He","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib85","series-title":"Optics","author":"Hecht","year":"1987"},{"key":"10.1016\/j.exer.2021.108617_bib86","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo","volume":"20","author":"Heneka","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2021.108617_bib87","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III","volume":"270","author":"Hertz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib88","series-title":"Histology of the Human Eye","author":"Hogan","year":"1971"},{"key":"10.1016\/j.exer.2021.108617_bib89","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1307211110","article-title":"Pathogenic role of diabetes-induced PPAR-\u03b1 down-regulation in microvascular dysfunction","volume":"110","author":"Hu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108617_bib90","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1167\/iovs.10-5768","article-title":"TNFalpha is required for late BRB breakdown in diabetic retinopathy and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis","volume":"52","author":"Huang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070785","article-title":"Topical rosiglitazone is an effective anti-scarring agent in the cornea","volume":"8","author":"Huxlin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108617_bib92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson's disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.exer.2021.108617_bib93","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archinternmed.2012.1938","article-title":"Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes","volume":"172","author":"Idris","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.exer.2021.108617_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5551\/jat.12.169","article-title":"CLOCK\/BMAL1 is involved in lipid metabolism via transactivation of the Peroxisome Proliferator-Activated Receptor (PPAR) response element","volume":"12","author":"Inoue","year":"2005","journal-title":"J. Alther. Thromb."},{"key":"10.1016\/j.exer.2021.108617_bib95","first-page":"645","article-title":"Activation of the member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Compos. Stud."},{"key":"10.1016\/j.exer.2021.108617_bib96","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.ajpath.2014.01.026","article-title":"'Inhibitory effects of PPARgamma ligands on TGF-beta1-induced corneal myofibroblast transformation","volume":"184","author":"Jeon","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108617_bib97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exer.2015.06.028","article-title":"Inhibitory effects of PPAR\u03b3 ligands on TGF-\u03b21-induced CTGF expression in cat corneal fibroblasts","volume":"138","author":"Jeon","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1242\/jcs.112.5.613","article-title":"The cellular basis of corneal transparency: evidence for \u201ccorneal crystallins\u201d","volume":"112","author":"Jester","year":"1999","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.exer.2021.108617_bib99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2007.09.015","article-title":"Corneal cyrstallins and the development of cellular transparency","volume":"19","author":"Jester","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.exer.2021.108617_bib100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.exer.2021.108617_bib101","doi-asserted-by":"crossref","first-page":"26395","DOI":"10.1074\/jbc.M114.583880","article-title":"Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor \u03b1 and suppressor of cytokine signaling 3","volume":"289","author":"Jiang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib102","first-page":"1418","article-title":"TNF-\u03b1 mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations","volume":"15","author":"Joussen","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108617_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/md17060321","article-title":"An algal metabolite-based PPAR-\u03b3 agonist displayed anti-inflammatory effect via inhibition of the NF-\u03baB pathway","volume":"17","author":"Ju","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.exer.2021.108617_bib104","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jdiacomp.2014.10.010","article-title":"Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy","volume":"29","author":"Katome","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.exer.2021.108617_bib105","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2021.108617_bib106","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2021.108617_bib107","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.visres.2017.03.011","article-title":"Do photoreceptor cells cause the development of retinal vascular disease?","volume":"139","author":"Kern","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2021.108617_bib108","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1096\/fj.01-0147com","article-title":"The peroxisome proliferator-activated receptor alpha regulated amino acid metabolism","volume":"15","author":"Kersten","year":"2001","journal-title":"FASEB"},{"key":"10.1016\/j.exer.2021.108617_bib109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017020231","article-title":"Peroxisome proliferated activated receptors (PPARs): opportunities and challenges for ocular therapy","volume":"35","author":"Khatol","year":"2018","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.exer.2021.108617_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2010.08.001","article-title":"Ciliary blood flow and aqueous humor production","volume":"30","author":"Kiel","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib111","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.4049\/jimmunol.175.9.5744","article-title":"Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation","volume":"175","author":"Kobayashi","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108617_bib112","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cmet.2017.04.029","article-title":"PPAR\u03b2 is essential for maintaining normal levels of PGC-1\u03b1 and mitochondria and for the increase in muscle mitochondria induced by exercise","volume":"25","author":"Koh","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.exer.2021.108617_bib113","article-title":"PPAR\u03b3 activation but not PPAR\u03b3 haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors","volume":"150","author":"Kotlinowski","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2021.108617_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8492353","article-title":"PPAR gamma and angiogenesis: endothelial cells perspective","author":"Kotlinowski","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.exer.2021.108617_bib115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40360-017-0169-y","article-title":"Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation","volume":"18","author":"Ku","year":"2017","journal-title":"BCM Pharmacol. Toxicol."},{"key":"10.1016\/j.exer.2021.108617_bib116","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11883-007-0033-4","article-title":"Atherosclerosis and cardiovascular risk reduction with PPAR agonists","volume":"9","author":"Kuusisto","year":"2007","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.exer.2021.108617_bib117","first-page":"1929","article-title":"Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor","volume":"37","author":"Kvanta","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/eye.2015.236","article-title":"Why rods and cones?","volume":"30","author":"Lamb","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108617_bib119","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.exer.2021.108617_bib120","doi-asserted-by":"crossref","first-page":"108094","DOI":"10.1016\/j.exer.2020.108094","article-title":"Corneal epithelial biology: lessons stemming from old to new","volume":"198","author":"Lavker","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib121","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.3390\/ijms20205182","article-title":"Complementary immunometabolic effects of exercise and PPAR\u03b2\/\u03b4 agonist in the context of diet-induced weight loss in obese female mice","volume":"20","author":"Le Garf","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib122","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/eye.2008.21","article-title":"Adult vitreous structure and postnatal changes","volume":"22","author":"Le Goff","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108617_bib123","doi-asserted-by":"crossref","first-page":"502631","DOI":"10.1155\/2011\/502631","article-title":"Peroxisome proliferator-activated receptor-\u03b1 activation decreases mean arterial pressure, plasma interleukin-6, and COX-2 while increasing renal CYP4A expression in an acute model of DOCA-salt hypertension","volume":"2011","author":"Lee","year":"2011","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2005.10.010","article-title":"PPAR-gamma agonist increase gefitinib\u2019s antitumor activity through PTEN expression","author":"Lee","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.exer.2021.108617_bib124","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2021.108617_bib125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR\u03b1 in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2021.108617_bib126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.cellbio.12.1.335","article-title":"Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology","volume":"12","author":"Lemberger","year":"1996","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.exer.2021.108617_bib127","article-title":"Inhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-\u03b3 and down-regulation of VEGFR-2 expression","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108617_bib128","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.3390\/ijms19113339","article-title":"The Role of PPAR-\u03b4 in metabolism, inflammation, and cancer: many characters of a critical transcription factor","volume":"19","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib129","first-page":"855","article-title":"Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes","volume":"37","author":"Lopez","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib130","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1167\/iovs.02-0588","article-title":"Age-related liquefaction of the human vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen","volume":"44","author":"Los","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib131","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/neu.20239","article-title":"Retinoids, eye development, and maturation of visual function","volume":"66","author":"Luo","year":"2006","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.exer.2021.108617_bib132","series-title":"StatPearls (Internet)","article-title":"Anatomy, head and neck, eye lacrimal gland","author":"Machiele","year":"2020"},{"key":"10.1016\/j.exer.2021.108617_bib134","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.jid.5701026","article-title":"Deficiency of PPARbeta\/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation","volume":"128","author":"Man","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.exer.2021.108617_bib135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"2Cell Mol. Life Sci."},{"key":"10.1016\/j.exer.2021.108617_bib137","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/B:AGEN.0000021377.13669.c0","article-title":"Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis","volume":"6","author":"Margeli","year":"2003","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2021.108617_bib138","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/0008-5472.CAN-17-0908","article-title":"PPAR\u03b4 elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth","volume":"78","author":"Mart\u00edn-Mart\u00edn","year":"2018","journal-title":"Canc. Res."},{"key":"10.1016\/j.exer.2021.108617_bib139","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.RES.83.11.1097","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells","volume":"83","author":"Marx","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2021.108617_bib140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nn0901-877","article-title":"The fundamental plan of the retina","volume":"4","author":"Masland","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exer.2021.108617_bib141","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/db19-0898","article-title":"Pathogenic role of PPARa down-regulated in corneal nerve degeneration and impaired corneal sensitivity in diabetes","volume":"69","author":"Matlock","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib142","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0092-8674(01)00401-9","article-title":"Regulation of clock and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock","volume":"105","author":"McNamara","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.exer.2021.108617_bib143","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1113\/expphysiol.2006.036376","article-title":"Signalling within the neurovascular unit in the mammalian retina","volume":"92","author":"Metea","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.exer.2021.108617_bib144","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200011148","article-title":"Impaired skin wound healing in peroxisome proliferator\u2013activated receptor (PPAR)\u03b1 and PPAR\u03b2 mutant mice","volume":"154","author":"Michalik","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2021.108617_bib145","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2003-032103","article-title":"Evidence for a potent antiinflammatory effect of rosiglitazone","volume":"89","author":"Mohanty","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2021.108617_bib146","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.exer.2021.108617_bib147","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/83328","article-title":"The role of PPAR-\u03b3 in macrophage differentiation and cholesterol uptake","volume":"7","author":"Moore","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2021.108617_bib148","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1167\/iovs.13-13127","article-title":"Protective and antioxidant effects of PPAR\u03b1 in the ischemic retina","volume":"55","author":"Moran","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib149","article-title":"Therapeutic effects of PPAR alpha on neuronal death and microvascular impairment","volume":"595426","author":"Moran","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib150","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib151","doi-asserted-by":"crossref","first-page":"41925","DOI":"10.1074\/jbc.M206950200","article-title":"Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms","volume":"277","author":"Mueller","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib152","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1074\/jbc.272.12.8071","article-title":"Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists","volume":"272","author":"Mukherjee","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib153","first-page":"157","article-title":"Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators","volume":"51","author":"Mukherjee","year":"1994","journal-title":"Compos. Stud."},{"key":"10.1016\/j.exer.2021.108617_bib154","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1167\/iovs.05-1432","article-title":"Effects of peroxisome proliferator-activated receptor \u03b3 and its ligand on blood\u2013retinal barrier in a streptozotocin-induced diabetic model","volume":"47","author":"Muranaka","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib155","first-page":"2309","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization","volume":"41","author":"Murata","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2021.108617_bib156","first-page":"1402","article-title":"Prenatal and postnatal growth of the human Descemet's membrane","volume":"25","author":"Murphy","year":"1984","journal-title":"Invest Opthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib157","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0896-6273(91)90380-I","article-title":"cGMP-gated conductance in retinal bipolar cells is suppressed by the photoreceptor transmitter","volume":"7","author":"Nawy","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.exer.2021.108617_bib158","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/346269a0","article-title":"Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells","volume":"346","author":"Nawy","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.exer.2021.108617_bib159","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/diacare.27.1.256","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"27","author":"Nesto","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2021.108617_bib160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib163","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/WNR.0b013e3282f7968f","article-title":"PPAR\u03b1 is involved in photoentrainment of the circadian clock","volume":"19","author":"Oishi","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.exer.2021.108617_bib164","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.lfs.2008.02.002","article-title":"PPAR alpha activators up-regulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation","volume":"82","author":"Okayasu","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2021.108617_bib166","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1167\/iovs.10-6826","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor-\u03b3 agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels","volume":"52","author":"Omae","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2021.108617_bib167","first-page":"972","article-title":"Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells","volume":"39","author":"Otori","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib168","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/ijms19030913","article-title":"Ppar\u03b2\/\u03b4: a key therapeutic target in metabolic disorders","volume":"19","author":"Palomer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib169","first-page":"2279","article-title":"Antifibrotic effect by activation of peroxisome proliferator-activated receptor\u2013\u03b3 in corneal fibroblasts","volume":"15","author":"Pan","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108617_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.08305FP","article-title":"Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells","volume":"111","author":"Park","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib171","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12915-017-0451-x","article-title":"PPAR\u03b1 is essential for retinal lipid metabolism and neuronal survival","volume":"15","author":"Pearsall","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.exer.2021.108617_bib172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208399","article-title":"Neuroprotective effects of PPAR\u03b1 in retinopathy of type 1 diabetes","volume":"14","author":"Pearsall","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108617_bib173","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1128\/MCB.20.14.5119-5128.2000","article-title":"Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)","volume":"20","author":"Peters","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2021.108617_bib174","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/641087","article-title":"PPAR and oxidative stress: con(\u03b2) catenating NRF2 and FOXO","volume":"2012","author":"Polvani","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2021.108617_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.survophthal.2020.02.005","article-title":"Diabetic keratopathy: insights and challenges","author":"Priyadarsini","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib175","series-title":"Neuroscience","article-title":"The retina","author":"Purves","year":"2001"},{"key":"10.1016\/j.exer.2021.108617_bib176","first-page":"283","article-title":"Peroxisome proliferator activated receptor-gamma and traumatic brain injury","volume":"3","author":"Qi","year":"2010","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.exer.2021.108617_bib178","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.3390\/ijms19113362","article-title":"Reactive oxygen species-mediated damage of retinal neurons: drug development targets for therapies of chronic neurodegeneration of the retina","volume":"19","author":"Rohowetz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib179","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/jpet.116.233106","article-title":"Vascular and central activation of peroxisome proliferator\u2013activated receptor-\u03b2 attenuates angiotensin II\u2013induced hypertension: role of RGS-5","volume":"358","author":"Romero","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.exer.2021.108617_bib180","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPAR gamma: a nuclear regulator of metabolism, differentiation and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib181","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11481-014-9582-9","article-title":"PPAR alpha signaling in the hippocampus: crosstalk between fat and memory","volume":"10","author":"Roy","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.exer.2021.108617_bib183","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/cells9051215","article-title":"Alzheimer's disease, a lipid story: involvement of peroxisome proliferator-activated receptor","volume":"9","author":"S\u00e1ez-Orellana","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.exer.2021.108617_bib184","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/diab.45.12.1661","article-title":"Thiazolidinediones in the treatment of insulin resistance and type II diabetes","volume":"45","author":"Saltiel","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.exer.2004.10.009","article-title":"Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-\u03b3 ligand","volume":"80","author":"Sarayba","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib186","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/DMDI.2007.22.4.279","article-title":"Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review","volume":"22","author":"Satarasinghe","year":"2007","journal-title":"Drug Metabol. Drug Interact."},{"key":"10.1016\/j.exer.2021.108617_bib187","first-page":"568","article-title":"RNA-seq identifies a role for the PPAR inverse agonist GSK0660 in the regulation of TNF alpha-induced cytokine signaling in retinal endothelial cells","volume":"21","author":"Savage","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108617_bib188","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41433-019-0494-z","article-title":"New anti-hyperglycemic agents for type 2 diabetes and their effects on diabetic retinopathy","volume":"33","author":"Saw","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108617_bib189","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.exer.2021.108617_bib190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exer.2013.11.013","article-title":"A role for the ciliary marginal zone in the melanopsin-dependentintrinsic pupillary light reflex","volume":"119","author":"Semo","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib191","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2337\/db18-1278","article-title":"A protective effect of PPAR\u03b1 in endothelial progenitor cells through regulating metabolism","volume":"68","author":"Shao","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2021.108617_bib192","doi-asserted-by":"crossref","first-page":"41589","DOI":"10.1074\/jbc.C300368200","article-title":"Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor \u03b2\/\u03b4","volume":"278","author":"Shaw","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib193","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.126.6.793","article-title":"Rosiglitazone and delayed onset of proliferative diabetic retinopathy","volume":"126","author":"Shen","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib194","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2007.04.002","article-title":"PPAR\u03b1 is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders","volume":"357","author":"Shirai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2021.108617_bib195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.684381","article-title":"Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone","volume":"116","author":"Sorrentino","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2021.108617_bib196","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0039-6257(99)00086-7","article-title":"Histologic and morphometric analysis of the choroid, bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes","volume":"44","author":"Spraul","year":"1999","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib197","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108617_bib199","first-page":"8232","article-title":"Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-\u03b2\/\u03b4","volume":"55","author":"Suarez","year":"2014","journal-title":"Retin. Cell Biol."},{"key":"10.1016\/j.exer.2021.108617_bib200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrg.2016.150","article-title":"Transcriptional architecture of the mammalian circadian clock","volume":"18","author":"Takahashi","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.exer.2021.108617_bib201","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2004.12.025","article-title":"Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes","volume":"93","author":"Tan","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.exer.2021.108617_bib202","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1101\/gad.207501","article-title":"Critical roles of PPAR\u03b2\/\u03b4 in keratinocyte response to inflammation","volume":"15","author":"Tan","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.exer.2021.108617_bib203","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1167\/iovs.18-24504","article-title":"Sleep deprivation induces dry eye through inhibition of PPAR\u03b1 expression in corneal epithelium","volume":"59","author":"Tang","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib204","first-page":"2685","article-title":"An optic nerve crush injury murine model to study retinal ganglion cell survival","volume":"50","author":"Tang","year":"2011","journal-title":"JoVE"},{"issue":"2","key":"10.1016\/j.exer.2021.108617_bib205","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1167\/iovs.08-2005","article-title":"Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase","volume":"50","author":"Tawfik","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib206","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1152\/japplphysiol.00515.2009","article-title":"How nuclear receptors tell time","volume":"107","author":"Teboul","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.exer.2021.108617_bib207","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1167\/iovs.14-15550","article-title":"Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions","volume":"56","author":"Thakran","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib208","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.3390\/ijms21155296","article-title":"Peroxisome proliferator-activated receptor beta\/delta agonist suppresses inflammation and promotes neovascularization","volume":"21","author":"Tobita","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib210","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.exer.2021.108617_bib211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pneurobio.2005.09.002","article-title":"Spontaneous patterened retinal activity and the refinement of retinal projections","volume":"76","author":"Torborg","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.exer.2021.108617_bib212","first-page":"2135","article-title":"An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model","volume":"19","author":"Uchiyama","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108617_bib213","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1167\/iovs.07-0964","article-title":"Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor","volume":"49","author":"Usui","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib214","first-page":"1007","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2021.108617_bib215","first-page":"693","article-title":"Loss of PPAR\u03b3 in endothelial cells leads to impaired angiogenesis","volume":"129","author":"Vattulainen-Collanus","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.exer.2021.108617_bib216","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/cells9051133","article-title":"PPAR beta\/delta and the hallmarks of cancer","volume":"9","author":"Wagner","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.exer.2021.108617_bib217","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/1074-5521(95)90045-4","article-title":"Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more","volume":"2","author":"Wahli","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.exer.2021.108617_bib218","article-title":"Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: a rare case report and literature review","volume":"97","author":"Wang","year":"2018","journal-title":"Med"},{"key":"10.1016\/j.exer.2021.108617_bib219","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cmet.2008.10.009","article-title":"Vascular PPAR\u03b3 controls circadian variation in blood pressure and heart rate through Bmal1","volume":"8","author":"Wang","year":"2008","journal-title":"Cell Metabol."},{"key":"10.1016\/j.exer.2021.108617_bib220","doi-asserted-by":"crossref","first-page":"107982","DOI":"10.1016\/j.exer.2020.107982","article-title":"Kertocytes promote corneal neovascularization through VEGFr3 induced by PPAR\u03b1 inhibition","volume":"193","author":"Wang","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib221","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1038\/oncsis.2016.41","article-title":"PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions","volume":"5","author":"Wang","year":"2016","journal-title":"Oncogenesis. Oncogenesis"},{"key":"10.1016\/j.exer.2021.108617_bib222","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(03)00269-1","article-title":"Peroxisome-Proliferator-activated receptor \u03b4 activates fat metabolism to prevent obesity","volume":"113","author":"Wang","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.exer.2021.108617_bib223","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1167\/iovs.13-13396","article-title":"Ppar? regulates mobilization and homing of endothelial progenitor cells through the HIF-1?\/SDF-1 pathway","volume":"55","author":"Wang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108617_bib225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cvsm.2007.10.006","article-title":"Oxidative stress and the eye","volume":"38","author":"Williams","year":"2008","journal-title":"Vet. Clin. North Am. Small Anim. Pr."},{"key":"10.1016\/j.exer.2021.108617_bib226","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1442-9071.2010.02363.x","article-title":"Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function \u2013 a review","volume":"38","author":"Willoughby","year":"2010","journal-title":"Clin. Exp. Ophtalmol."},{"key":"10.1016\/j.exer.2021.108617_bib242","article-title":"Bowman\u2019s layer in the cornea- structure and function and regeneration","author":"Wilson","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108617_bib228","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1301\/nr2004.jun253-255","article-title":"Tissue\u2010specific knockout defines peroxisome proliferator\u2010activated receptor gamma function in muscle and liver","volume":"62","author":"Wolf","year":"2004","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.exer.2021.108617_bib229","first-page":"E2563","article-title":"Structural basis for specific ligation of the peroxisome proliferator-activated receptor \u03b4","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.exer.2021.108617_bib230","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1074\/jbc.274.13.9116","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands are potent inhibitors of angiogenesis in vitro and in vivo","volume":"274","author":"Xin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108617_bib231","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1128\/MCB.20.21.8008-8017.2000","article-title":"Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators","volume":"20","author":"Yang","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2021.108617_bib232","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2006.06.050","article-title":"Nuclear receptor expression links the circadian clock to metabolism","volume":"126","author":"Yang","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.exer.2021.108617_bib233","first-page":"13","article-title":"Corneal innervation and sensation: the eye and beyond","volume":"91","author":"Yang","year":"2018","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.exer.2021.108617_bib243","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/275435","article-title":"Role of peroxisome proliferator-activated receptor gamma in ocular diseases","author":"Zhang","year":"2015","journal-title":"J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2021.108617_bib234","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1091581810376674","article-title":"WY-14 643, a selective PPAR{alpha} agonist, induces proinflammatory and proangiogenic responses in human ocular cells","volume":"29","author":"Zhang","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.exer.2021.108617_bib235","first-page":"1003","article-title":"The molecular mechanisms of action of PPAR-\u03b3 agonists in the treatment of corneal alkali burns (Review)","volume":"38","author":"Zhou","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.exer.2021.108617_bib236","article-title":"Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: a rare case report and a review of the literature","volume":"99","author":"Zhou","year":"2020","journal-title":"Med"},{"key":"10.1016\/j.exer.2021.108617_bib237","article-title":"The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPAR\u03b3 in retinal neuroprotection","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:11:47Z","timestamp":1757999507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":228,"alternative-id":["S0014483521001834"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108617","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of peroxisome proliferator-activated receptors in healthy and diseased eyes","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108617"}}